Name: CANCELLED! Kevin Chapman: Cross Cultural Considerations in the Assessment and Treatment of Anxiety Disorders
Start: 2022-11-08T09:00:00+1300
End: 2022-11-08T10:30:59+1300
Location: Zoom

A 90 minute presentation with Dr Kevin Chapman (USA)

DUE TO UNFORSEEN CIRCUMSTANCES, THIS EVENT HAS BEEN CANCELLED

Cross Cultural Considerations in the Assessment and Treatment of Anxiety Disorders

This workshop will explore cultural factors and their impact on both the presentation of and the treatment for anxiety disorders with racial and ethnic minorities. Though much is known about anxiety disorders in general, there remains a scarcity of work with ethnic and racial minority groups. This workshop will particularly explore cultural considerations in the treatment of anxiety disorders. Specifically, we will explore common myths associated with anxiety disorders as well as cultural factors that impact the presentation of anxiety disorders in racial and ethnic minorities as well as common barriers associated with anxiety disorder treatment.

Learning Objectives

Identify common myths associated with anxiety disorders in racial and ethnic minorities.
Identify cultural factors that contribute to the presentation of anxiety disorders in racial and ethnic minority populations
Explore culturally-specific treatment barriers associated with racial and ethnic minority groups
Explore cultural ingredients to enhance anxiety treatment with racial and ethnic minorities

This session will be recorded for those who are registered but are unable to attend on the day.

Dr Kevin Chapman

Dr. Chapman is a Licensed Clinical Psychologist, founder and director of the Kentucky Center for Anxiety and Related Disorders (KYCARDS) where he specializes in the assessment and treatment of anxiety and related disorders. Dr. Chapman is a Diplomate and Certified by the Academy of Cognitive Behavioral Therapies (A-CBT), and is a internationally recognized expert in the implementation of cognitive behavioral therapy (CBT) for anxiety and related disorders. Additionally, Dr. Chapman serves as a consultant for the creation of evidenced-based, anxiety treatment protocols due to his additional expertise related to the intersection of multiculturalism and mental health. Similarly, Dr. Chapman has published numerous papers in scientific journals and has written several book chapters. Dr. Chapman is a Faculty member for the Behavior Therapy Training Institute (BTTI) for the International OCD Foundation (IOCDF) and serves on its Clinical and Scientific Advisory Board. Dr. Chapman also serves as a Mental Health Expert for TrueSport, a subsidiary for the United States Antidoping Agency (USADA). Dr. Chapman serves on several Editorial Boards including the Journal of Anxiety Disorders and Clinical Child and Family Psychologist Review. Additionally, Dr. Chapman is a Media Psychologist and regularly contributes to and serves as a consultant for multiple media outlets including A&E and other production companies. Along these lines, Dr. Chapman is also on the Psychology Expert Media Panel for the Coalition for the Application and Advancement of Psychological Science (CAAPS). Most recently, Dr. Chapman was the Program Psychologist for Seasons 1 and 2 on A&E's hit documentary 60 Days In. Dr. Chapman has been featured in US News and World Report, USA Today, NBC Health, Bloomberg Business Week, Men's Health, and numerous other outlets including the Nick News documentary Worried Sick: Living with Anxiety, a feature on adolescent anxiety. Dr. Chapman also serves as the Team Psychologist for the Louisville City Football Club (USL) and the Racing Louisville Football Club (NWSL). Dr. Chapman previously served as an Associate Professor in Clinical Psychology. Dr. Chapman completed a BS in Psychology from Centre College, a MS in Clinical Psychology from Eastern Kentucky University, and a Ph.D. in Clinical Psychology from the University of Louisville. Dr. Chapman was a two-sport collegiate athlete (track and field, football) and was inducted into the Centre College Athletic Hall of Fame in 2020. .